What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
For those seeking a non-surgical alternative to procedures like liposuction, AOD9604 provides an equally effective solution without the risks and recovery time associated with invasive treatments
Stress, dehydration, too much screen time, not enough sleep these everyday headaches are uncomfortable, but they're usually short-lived and respond well to rest and over-the-counter pain relievers
Wang H, Li L, Qin LL, Song Y, Vidal-alaball J, Liu TH
Could I still be low on B12
Weight loss begins but may be modest, averaging 2-4 pounds depending on starting weight and dose